CDI Labs empowers researchers to decipher the causative link between autoantibodies and disease, enabling them to create breakthrough treatments and diagnostics. CDI Labs provides transformational tools and services for proteome-wide, autoantibody profiling and biomarker discovery, including the HuProt™ Human Proteome Microarray, the largest collection of full-length proteins available, and HuScan® Human Proteome PhIP-Seq services for epitope-level autoantibody profiling.